Latest Asx Listing Rules News

Cavalier Resources has secured a $4 million placement at an 11.95% discount to the 15-day VWAP, funding critical pre-production activities at its Crawford Gold Project. This capital injection complements ongoing negotiations for a US$13 million gold prepayment and a A$5 million loan, advancing the project toward production.

Qube Holdings has obtained an ASX waiver allowing it to deviate from the standard scheme of arrangement timetable, enabling a fully franked special dividend payment and accommodating bidder funding arrangements. The board unanimously recommends shareholder approval, contingent on independent expert support and absence of superior proposals.

Gateway Mining attributes recent share price gains to a newly published independent research report, while confirming ongoing assay results from its Yandal Project remain under review and will be disclosed progressively starting 22 April 2026.

Tusker Minerals Ltd has seen its TSKO securities suspended from ASX quotation immediately due to non-compliance with listing rules. The suspension applies solely to this security class while the company works to meet regulatory requirements.

Toro Energy has secured an ASX waiver allowing it to cancel 4.4 million unlisted options for cash without shareholder approval, clearing a key procedural hurdle in its pending acquisition by IsoEnergy.

Australian Silica Quartz Group (ASQ) is set to acquire Australian Kaolin, adding a 47Mt inferred kaolin resource at White Swan and launching a $750,000 placement to fund development. The deal hinges on shareholder approval and an Independent Expert’s fairness opinion.

VHM Limited has secured A$5 million through a fully underwritten placement priced at A$0.26 per share, funding critical early engineering and procurement ahead of a mid-2026 final investment decision for its Goschen Rare Earth and Mineral Sands Project.

Patrys has raised A$3.2 million through a share placement to fund its injectable quetiapine program’s Phase 1A clinical trial and FDA pre-IND preparations.

Highfield Resources (ASX:HFR) has dismissed any undisclosed material information as the cause of its recent share price jump, attributing the volatility to global geopolitical tensions impacting fertiliser raw materials.

Atomo Diagnostics has responded to ASX queries confirming it first held market-sensitive information after Lumos Diagnostics’ FDA CLIA waiver approval for FebriDx. The company defended its trading halt and capital raise timing, asserting full compliance with ASX Listing Rules.

Lithium Plus Minerals has secured A$2.15 million through a discounted placement, backed by cornerstone investor Suzhou CATH and institutional buyers, to fund development and exploration at its Bynoe lithium project.

Multistack International has formalised the sale of nearly all its assets and liabilities to Hong Kong-based Willing Y Limited, marking a decisive end to its loss-making operations. The transaction hinges on shareholder and regulatory approvals, with completion targeted for June 30, 2026.